Asynchronous Skin Cancer Risk Using 3D Total-Body Photograph
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 24-008418
Sponsor Protocol Number: 24-008418
About this study
The purpose of this study it to compare two approaches for executive health skin cancer screening to assess the level of agreement between asynchronous 3D-Total Body Photography based examination and dermatology clinician exam.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- 18 years of age or older at time of consent.
- Patient has previously been seen in Executive Health within the past 18 months.
- Patient is scheduled with a medical appointment in the Executive Health Section in GIM RST.
- Patient is scheduled for a skin check medical appointment in Dermatology.
- Not pregnant by subject self-report at the time of consent.
- Have the ability to provide informed consent.
- Have the ability to complete all aspects of this trial.
- Have no contraindicating comorbid health condition which would interfere with the use of the WB360 system, as determined by the clinical investigators.
Exclusion Criteria:
- An unstable medical or mental health condition as determined by the physician investigator.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 09/10/2024. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Amirala Pasha, D.O., J.D. |
Open for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available